PGI Rohtak to start phase-2 human clinical trial of Bharat Biotech's Covid vaccine
Video Credit: HT Digital Content - Duration: 01:48s - Published
PGI Rohtak to start phase-2 human clinical trial of Bharat Biotech's Covid vaccine
Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine.
“We got permission from Bharat Biotech to start a phase-2 human clinical trial of their vaccine.
We've 300 volunteers, aged between 12 years and 65- years, out of which screening of 15 has been completed,” said Dr OP Kalra, vice-chancellor, PGI Rohtak.
Kalra also informed that in the phase-2 trail, they have recruited volunteers who have controlled diabetes and high blood pressure.
Watch the full video for more details.
![Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister [Video]](https://video.newsserve.net/300/v/20200930/2009301756-Covid-vaccine-Covaxin-phase-trials-on.jpg)
![Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials [Video]](https://video.newsserve.net/300/v/20200930/2009301314-Moderna-and-Regeneron-Jump-on-Positive-Covid-19.jpg)
![Bharat Biotech will involve 3,000 people for phase-III trials of COVID vaccine in UP [Video]](https://video.newsserve.net/300/v/20200930/2009300717-Bharat-Biotech-will-involve-000-people-for.jpg)
